TDP-43 protein deposition is often observed in AD with prominent hippocampal sclerosis (28); as CSF biomarker measurement of TDP-43 has limited utility, pathological assessment of TDP-43 in addition to amyloid plaques and tau neurofibrillary tangles should be included in LOEU cases. The gene discussed is MAPT; the disease is Alzheimer disease.